A Phase I Study of TQB3616 on Tolerance and Pharmacokinetics
Clinical trial NCT03850873 · COMPLETED
Trial details
- NCT number
- NCT03850873
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-20
- Primary completion
- 2021-09-23
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.